The Latest Breaking News from JNJ

Rising chronic diseases, an aging population, and surging healthcare spending should boost the pharmaceutical industry’s growth prospects. Moreover, the pharmaceutical industry usually holds up well during market downturns due to relatively inelastic demand for their products and services. Therefore, fundamentally sound pharma stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and…

Covid vaccines took a major toll on Johnson & Johnson and Danaher early Tuesday, hitting J&J's fourth-quarter sales and Danaher's guidance.

With the Fed’s progressive interest-rate hikes keeping markets in perpetual turmoil, strong fundamentals of Johnson & Johnson (JNJ) could help investors secure decent risk-adjusted returns on their investments. Read on….

The Fed’s indication to keep raising interest rates through this year and looming recession fears will likely keep the stock market under pressure for the near term. Therefore, investors looking for stability amid an uncertain macroeconomic environment could consider buying fundamentally strong dividend-paying healthcare stocks Johnson & Johnson (JNJ), Pfizer…

With concerns of a recession weighing heavily on investors’ decisions, well-reputed companies paying stable dividends could be smart investments for investors over 50. Therefore, it might be wise for investors to buy fundamentally strong stocks like Johnson & Johnson (JNJ) and Coca-Cola (KO). Read more….

With the Fed expected to keep rates higher throughout this year, the odds of the economy tipping into a recession are rising. Amid ongoing macroeconomic uncertainties, investors may consider buying companies with reliable performance over the years for solid long-term returns. To that end, Pfizer (PFE), Johnson & Johnson (JNJ),…

With interest rates expected to increase throughout this year, the stock market will likely remain under pressure. Amid the anticipated volatility in the stock market this year, investors may consider investing in stable and dividend-paying stocks Johnson & Johnson (JNJ), The Procter & Gamble Company (PG), and AptarGroup (ATR) to…

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

Johnson & Johnson (JNJ) continued its business momentum in the third quarter of fiscal 2022, driven by steady demand for its products and innovative, advancing portfolio and pipeline. Moreover, the company has a record of raising its dividend for 60 consecutive years. Amid the current uncertain market conditions, this fundamentally…

Recession fears are rampant in the face of widespread macroeconomic headwinds and will likely keep the stock market under pressure in the upcoming months. Therefore, it could be ideal to buy and hold industry-leading stocks, Microsoft Corporation (MSFT) and Johnson & Johnson (JNJ), that are well-positioned to help navigate a…

Well-known investor Warren Buffett has created his fortune through a value investing strategy. With an incredible track record, his investment portfolio has been religiously tracked by investors for decades. Amid ongoing economic uncertainties, fundamentally strong Warren Buffett stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and Diageo (DEO) could be solid…